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ABSTRACT
We have developed a directed DNA sequencing
strategy based upon the Escherichia coli transposon
Tn3. This transposon displays little sequence
specificity for transposition and is thus well suited to
this task. Both mini-Tn3 transposons and sequencing
vectors bearing the phage f1 single stranded origin of
replication have been constructed. Upon mutagenesis
of a target sequence, a population is produced in which
each clone has two fl origins of replication, one of
which is at a variable position depending upon the
tranposon insertion site. When helper phage is added
to the mutagenised population, the two fl origins
present on each clone are nicked, dividing the
packaged strand into two segments, each of which is
packaged into a separate phage particle. One of these
segments contains no resistance markers and is lost,
whilst the other is recovered as a deleted clone with
a single chimeric f1 origin. A unidirectionally, variably-
deleted set of sequencing clones is produced, and
appropriately sized clones are sequenced using a
primer complimentary to the transposon end. In
addition to being inexpensive, the method does not
require the same degree of technical expertise needed
for many in vitro, enzymatically based methods. The
strategy has been used to determine 2.6 kilobases of
nucleotide sequence in the Saccharomyces cerevisiae
ADE 1 locus.
INTRODUCTION
Directed DNA sequencing strategies often involve the generation
of overlapping deletions, made in a progressive, enzymatically-
based manner from one end of a population of linear DNA
fragments, such that after recircularisation a different sequence
in each clone lies next to an invariant priming site (1, 2, 3). The
position in the fragment which will be sequenced is related to
the size of the deletion, and hence to the overall size of the clone.
Thus, one can sequence a given region by selecting an
appropriately sized clone. Other directed strategies exploit DNAse
1 nicking activity (4) or Tn9 transposon insertion (5), but are
relatively sequence specific and are not in common use. These
GenBank accession no. M67445
directed strategies are designed to minimise the amount of
redundant sequence data that is generated, but are usually
technically complex and labour intensive. Also, the underlying
enzymologies have inherent sequence specific biases that can
result in the underrepresentation of certain size classes of clones.
The Tn3 transposon family, which includes Tn3 and gamma
delta, displays relatively little insertion site specificity compared
to other transposons. This property can be exploited in the
development of DNA sequencing strategies. Directed strategies
based upon the in vivo transposition of the transposon gamma
delta have recently been reported. These strategies use restriction
digestion and Southern hybridisation (6), and the polymerase
chain reaction (7) to map insertion events. We present here a
low cost and simple directed strategy that is based on the
transposon Tn3. The strategy is based upon transposon insertion
followed by an in vivo site-specific deletion that generates
packaged, single-stranded DNA clones of different sizes. Briefly,
transposon mutagenesis is first carried out in Escherichia coli
by a previously described, simple and effective procedure (8).
A deletion event is then catalysed in vivo between two phage fl
origins of replication, one on the transposon and one based on
the target plasmid, by taking advantage of the nicking activity
at those origins during replication and packaging of single-
stranded DNA (9). The size of the deletion is dependent upon
the transposon insertion site. Deleted clones are then directly
assayed for size by agarose gel electrophoresis of undigested,
packaged, single-stranded DNA, and appropriately sized clones
are sequenced from a priming site at the transposon terminus.
The advantages gained by this system over the mapping strategies
employed in the gamma delta systems (6, 7) are that it does not
necessitate either DNA purification, restriction digestion and
Southern hybridisation or the use of a polymerase chain reaction
(which can be unreliable for larger fragments) to map insertion
sites in identically sized molecules. Instead, the generation of
a deletion in vivo allows direct size assay by agarose gel
electrophoresis to map transposon insertion sites. This method,
as employed in other single-stranded strategies, is inexpensive,
quick and reliable.
We have applied this 'Tn3 deletion' sequencing strategy to a
DNA fragment encoding the Saccharomyces genes ADEJ and
part of FUN2 (10).
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MATERIALS AND METHODS
Construction of vectors and transposons
Construction of pHSS6/fl: The fl origin from pUC flSH-K (a
gift from H. Fried) was subcloned as a Sma I/Hpa I fragment
into the pHSS6 (8) Sma I site. Transformants were picked and
tested for packaging function, and then the orientation of the fl
origin was determined by restriction analysis. Construction of
pUNC9(+) and pUNC9(-): The Not I polylinker fragment in
pHSS6/fl was replaced with the Not I ai lacZ and pUC9
polylinker fragment from pHSS8 (11). The transformants were
screened for a complementation, restriction digested and
sequenced using universal primer (12) to determine the two
orientations for pUNC9( +) and 9(-). Construction of
pUNC19(+) and pUNC19(-): The Eco RI/Hind III polylinker
fragments from pUNC9(+) and 9(-) were replaced with the
corresponding fragment from pUC 19. Construction of mini-Tn3
UFO: The fl origin fragment (above) was cloned into the end-
repaired Eco RI site of m-Tn3 URA3 (8) and tested as above.
Construction of mini-Tn3 FOa: The fl origin fragment (above)
was cloned into the end-repaired Hind III site of m-Tn3. The
end-repaired Not I fragment from pHSS8 (the ae lacZ/polylinker
fragment) was then cloned into the end-repaired Eco RI site of
this construct and tested as above. The Klenow fragment of
E. coli polymerase I was used for all end repairs.
Construction of the helper phage M13C07
The helper phage M13C07 is a derivative of the kanamycin
resistance-conferring helper phage M13K07. A mini-TnlO
transposon (13), conferring chloramphenicol resistance to the host
strain, was transposed into M 13K07 and the packaged
supernatant was selected for the ability to transduce this marker
into a host strain. Individual transductants were then screened
for kanamycin resistance. Sensitive transductants were assumed
to harbour a TnlOd insertion into the kanamycin resistance gene,
inactivating it. Insertions of this type were recovered with a high
frequency, since this is one of the few non-essential regions in
M13K07 (when not under selection for kanamycin resistance).
Source of the test sequence
A 3.0 kb Not I fragment encoding the S. cerevisiae gene ADE],
part of FUN2 and some pBR322 sequence (10) was subcloned
from pHSS4/ADEJ (8) in both orientations into pHSS6/fl to
create the plasmids pHSS6/fl/ADEJ. 13 and pHSS6/fl/ADEJ. 15.
Transposon mutagenesis
Transposon mutagenesis was carried out as previously described,
using the E. coli RecA- strains described therein (8,11), with
some modifications (Figure 1, A -D). The procedure is described
here for a single transformant: The plasmid pHSS6/fl/ADEJ was
transformed into an F- strain containing pLB101, the source
of the Tn3 transposase. A 2ml overnight culture of a transformant
was grown in 2YT (chloramphenicol 12.5/g/ml, kanamycin
25,tg/ml). Similarly, a 2ml overnight culture of an F+ strain
harbouring the transposon based on a conjugative plasmid was
grown (in 2YT, ampicillin 100.ug/ml). The next day, the two
strains were mated to transfer the transposon to the cell
harbouring the target DNA: A l00,^d aliquot of each culture was
diluted 1:20 into fresh media without antibiotics in a 15ml tube
and grown for 2 hours at 37°C with shaking. The cells were
allowed to mate by combining the contents of the two tubes and
incubating at 37°C for 30 minutes without shaking. A 1ltl aliquot
was then diluted to 100 tl in fresh medium and immediately plated
out (chloramphenicol 12.5ltg/ml, kanamycin 25/Ag/ml, ampicillin
I00Aglml) and incubated at 30°C overnight to allow transposition
and cointegrate formation to occur. At the same time, a 2ml
overnight culture of the E. coli strain NS21 14Sm (the source of
cre recombinase) was prepared (in 2YT, streptomycin 1001Lg/ml).
The next day, the approximately 1000 to 2000 cointegrate-
containing colonies were resuspended in 2ml of medium. A small
aliquot of the suspension was added to 2ml of liquid medium
such that the turbidity appeared to be approximately the same
as that of a 1:20 dilution of the NS2114Sm culture. These
dilutions were then grown and mated as above, and an aliquot
plated out (kanamycin 25,^g/ml, ampicillin 100lg/ml,
streptomycin 1001ig/ml) and incubated overnight at 37°C. The
colonies seen the next day were assumed to each represent an
insertion of the transposon into the target sequence. In practice,
this mutagenesis was carried out separately and in parallel for
at least two individual transformants from each orientation of the
ADE] insert in the target plasmid. At the very least then, each
plate carried a different profile of insertion events, and at best
each colony represented a unique insertion event.
Generation of deletions
Colonies from the final step of the transposon mutagenesis were
pooled in liquid media and vortexed thoroughly (Figure 1, D-F).
A lml aliquot was frozen at -70°C as a 20% glycerol stock,
and another aliquot was grown in liquid media (kanamycin
25,ug/ml, ampicillin 100/Ag/ml, streptomycin 100ltg/ml) at 37°C
until mid log phase. At this point the helper phage M13CO7 (and
chloramphenicol, 12.5,ug/ml, 20 minutes later) were added, and
the culture was sampled at 2, 4 and 12 hours (or overnight) post
infection. Samples were immediately microfuged and the
supernatant incubated at 65°C for 15 minutes to kill live cells.
Reinfection, assay of clones and template preparation
Supernatants containing deleted clones were reinfected into the
E. coli strain DH5 a F' at low titer to give isolated colonies.
Colonies were picked, and single-stranded packaged phagemid
was prepared as previously described (12) and directly assayed
for size by agarose gel electrophoresis. Single stranded template
DNA was prepared either from 1.5ml cultures (14) or from 2401I
cultures grown in 96-well microtitre plates (15,16).
DNA sequencing
Suitably-sized templates were sequenced with an oligonucleotide
complementary to the 3' end of the (3-lactamase gene on m-Tn3
(5' AATCTCATGACCAAAATCCC 3'), using the dideoxy
chain-termination method (17) and buffer gradient acrylamide
gels, following the protocols of Bankier et al. (14).
Sequence analysis computer programs
DNA sequence was compiled and analysed using the Staden
DBSYSTEM programmes (18), and further analysed using the
GCG program package version 6.2 (19). Database searches were
performed using the FastA algorithm of Pearson and Lipman (20)
on the most recent version of Genbank available by electronic
mail (November, 1990).
RESULTS
Rationale of the 'Tn3 deletion' sequencing strategy
The transposon E. coli Tn3 typically encodes both the sequences
necessary for transposition and an accessory gene such as 3-
lactamase, encoding ampicillin resistance. Tn3 displays no strong
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Figure 2. Mini transposons used in Tn3-deletion sequencing.
insertion site specificity, although it displays a mild regional
specificity for adenosine and thymidine rich sequences. Other
transposons, such as Tn5, 9 and 10, are more prone to insertion
site specificity (21).
The sequencing strategy presented here is a development of
the Tn3-based transposon mutagenesis method described by
Seifert et al. (8), which efficiently produces a large number of
mutagenised clones, each with an effectively randomly placed
transposon insertion in the target sequence, and with very little
background of non-useful insertion events such as multiple
insertions or insertions into the E. coli genome. All mutated
clones carry a complete copy of the target sequence disrupted
by a single, randomly-placed insertion of mini-Tn3, and are thus
identical in size. While quite complex in theory, the method is
in fact simple to execute. (See Figure 1, A-D and method
section.)
We have constructed both mini-Tn3 transposons and target
vectors that carry an fl phage single-stranded origin of replication
(figures 2 and 3). The target vectors are thus in effect phagemids.
After transposon mutagenesis using these constructs a molecule
with two fl origins is created, which is exploited as follows to
create a site-specific deletion: When the single-stranded phages
M13 and fl replicate, the packaged strand is nicked at the origin
of replication. A molecule carrying two of these single-stranded
origins is nicked at both of these sites during replication, and
is cleaved into two pieces which recircularise and are packaged
independently (9). Presumably both pieces of the parent give rise
to packaged material, but only that piece which encodes the
ampicillin and kanamycin resistance determinants and the
bacterial replication origin is recovered. Thus, a deletion is made
in each mutagenised phagemid, the size of which is determined
by the transposon insertion site. The deleted DNA contains non-
essential vector and transposon sequences, and a piece of target
DNA located in between. Insertions into vector DNA inactivate
or result in the deletion of essential sequences and are not
recovered. A randomly mutagenised population, therefore, gives
rise to a randomly-deleted population can be used to sequence












Figure 3. Target vectors used in Tn3-deletion sequencing. * denotes sites in
polylinker present more than once in vector.
It should be noted that the mini-Tn3 can insert in either
orientation, but only transposition events which place both fl
origins in the same orientation on a phagemid give rise to a
successful deletion and packaging event. Insertions in the other
orientation package very inefficiently or not at all, and also would
not carry all of the determinants necessary for survival. Thus,
deletions are made from one end of the target DNA for a given
orientation in the vector, allowing each strand to be deleted and
sequenced independently.
The deletion event is mediated by simply adding helper phage
to a liquid culture of the mutant bank, and the packaged, deleted
target molecules are harvested from the supernatant. These are
then reinfected at low titer into a host suitable for single-stranded
sequencing template production, and are plated out onto
appropriate selective media. Individual clones are picked, helper
phage added, and packaged phagemid from the supernatants
assayed for size by agarose gel electrophoresis. Suitably sized
clones over the extent of the observed size range can be sequenced
using an oligonucleotide primer complementary to the end of the
mini-Tn3, allowing sequence in the target DNA to be read.
Vector and transposon design
Several vectors and mini-Tn3 transposons were constructed
during the development of the method (figures 2 and 3). The
vectors are all kanamycin resistant, carry an fl origin of
replication in the necessary orientation, and lack a copy of the
Tn3 38 base pair (bp) terminal repeat that is closely linked to
f3-lactamase in most vectors and which confers immunity to Tn3
transposition. The vectors' small size (approx. 3 kb) allows them
to carry large inserts. pUNC9(+), 9(-), 19(+) and 19(-) carry
the a lacZ fragment and thus allow easy cloning by screening
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for white colonies on X-gal medium, at the expense of providing
a little more target DNA that does not yield useful sequence.
Mini-Tn3 transposons carrying fl origins in the required
orientation were constructed. m-Tn3 UFO is of use when one
wishes to reintroduce a disrupted clone into S. cerevisiae. m-
Tn3 FOa carries the a lacZ fragment from pUC9 which is retained
after the deletion event, and allows subsequent manipulation of
the remaining target sequence (see discussion).
Construction of the helper phage M13CO7
The kanamycin resistance-conferring helper phage M13KO7
packages phagemid with high efficiency, but is not the helper
phage of choice for phagemids that also encode kanamycin
resistance. The interference-resistant phage R408 was also found
to be unsuitable. We have disrupted the kanamycin resistance
gene of M13KO7 with a defective TnlO transposon (13) that
carries the chloramphenicol resistance gene, to create a
chloramphenicol resistant, kanamycin sensitive helper phage
designated M13CO7. It is this phage that we have used to produce
the deletions in the mutated target vectors, and also to package
the deleted clones for template preparation. We have found this
helper phage to have the same beneficial packaging characteristics
as M13KO7.
Test sequencing project
The Tn3 deletion sequencing strategy was applied to a 3.0 kb
fragment encoding the S. cerevisiae gene ADE] (phosphoribosyl-
amino-imidazolesuccinocarboxamide synthetase [EC 6.3.2.6]),
which functions in the adenine biosynthesis pathway, and part
of FUN2, a non-essential gene of unknown function (10). The
fragment was subjected to transposon mutagenesis,
M13CO7-mediated deletion, reinfection, assay for size, and
sequencing in both orientations as described in 'materials and
methods' and outlined in figure 1.
Size distribution of clones produced during the sequencing
of the ADEI locus
A total of 102 clones were sequenced to determine the complete
nucleotide sequence of this fragment on both strands, with an
average of 5.6-fold redundancy per base. 78 of these were on
the [ + ] strand (i.e. same sense as ADE] mRNA), and 24 were
on the [-] strand. All clones chosen for sequencing were
sequenceable with the f-lactamase primer. Additionally, all of
the clones sequenced were of the correct size on the agarose gel
when compared to their predicted size from the sequence data,
demonstrating the efficiency and faithfulness of the deletion
method. To show the random clone-size distribution that can be
obtained, 40 clones from the [ + ] strand were randomly picked
and sized by agarose gel electrophoresis (figure 4). Calculation
of the sizes of these clones (based on migration distance and
sequence data) shows that in all probability the complete sequence
could be determined from this population, requiring gel readings
of approximately 250 bp and one long reading of 400 bp.
On the [ + ] strand, many clones of the same apparent size were
intentionally sequenced, so that possible biases in the distribution
of clones could be analysed. It was found that clones of the same
apparent size on an agarose gel were sometimes a few base pairs
different in size, and were sometimes identical. Identical clones
could arise from two separate insertions into an identical position,
or could be sibling clones from the same insertion event.
The [-] strand of this clone suffered from a sequence-related
artefact that resulted in reduced yields of packaged phagemid.
Figure 4. Agarose gel fractionation of single-stranded clones bearing transposon/fl
origin-mediated deletions in a 3.1 kilobase ADEI-encoding fragment. Selected
clones were sequenced to confirm that deletions were over the full range of the
fragment. Vector sequences remaining are 3.7 kb in size, hence the largest (upper)
clones are approximately 6.8 kb, and the smallest 3.8kb.
Artefacts of this type are encountered occasionally with all single-
stranded vectors, and may be solved (or not!) by changing the
vector, insert orientation, helper phage or host strain. In the case
of the sequence reported here, the artefact was manifested in the
following manner: 75% of the deleted clones picked and sized
by agarose gel electrophoresis were small, with approximately
80% or more of the sequence deleted, and gave a normal DNA
yield (as determined by ethidium bromide staining). The
remaining clones were evenly distributed in size, with between
0 and 80% of the clone deleted, but were of relatively poor DNA
yield (data not shown). We surmise that a sequence in the target
DNA, located at a position approximately 80% along the
fragment, was inhibitory to the packaging of single stranded
phagemid in this orientation, and that only clones in which this
sequence was deleted produced normal titers of phagemid. During
the en masse generation of deletions, therefore, clones which
deleted 80% or more of the target sequence would also delete
this inhibitory sequence, would be packaged in higher titers than
clones giving rise to smaller deletions, and consequently were
picked more frequently when choosing clones for size assay. This
bias, then, can be attributed not to transposon specificity but to
a packaging artefact caused by the sequence of the ADEl insert.
We have not encountered a similar artefact in clones sequenced
subsequently by this method. Despite this problem, size assay
of 192 colonies picked and grown in 96-well microtiter plates
yielded enough suitably-sized clones to determine the complete
the sequence of the [-] strand. Contiguous sequence in this
orientation was obtained from 24 clones, emphasising the
advantage of a directed approach.
Sequence analysis of the ADEI locus
The nucleotide sequence of the single copy ADEI locus and the
predicted protein sequences of the long open reading frames
(ORFs) corresponding to ADE] and FUN2 are shown in figure
5. This sequence is available in Genbank under the accession
number M67445.
The only complete, long ORF in the fragment exists at the
position in the locus shown previously to encode ADEI (8). The
predicted protein sequence is 306 amino acids (a.a.) in length.
This sequence was compared to the NBRF protein and the
translated Genbank databases and was found to bear most
homology to the Bacillus subtilis and E. coli enzymes of the same
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Figure 5. Nucleotide sequence of the S. cerevisiae ADEI locus on chromosome I, including partial sequence of the FUN2 gene.
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Figure 6. Alignment of the phosphoribosyl-amino imidazole succinocarboxamide synthetase [EC 6.3.2.6] homologues ADEI (S. cerevisiae), purC (B. subtilis [B.su]),
and purC (E. coli [E. co]).
name and function, encoded by the purC genes (22, 23). A
composite alignment, optimised manually, is shown in figure 6.
Several motifs appear to be conserved, presumably due to their
recognition of common substrates. We assume, based upon this
alignment and primer extension extension studies on ADEI
mRNA (data not shown), that the ATG codon at nucleotide
position 932 (figure 5) is the start codon used. Nucleotides 701
to 2147 (encompassing the ADE] coding sequence) correspond
to previously sequenced S. cerevisiae ADE] (24) which recently
became available in the Genbank database (13 September 1990,
accession number M3833 1). The two sequences differ at seven
nucleotide positions, possibly due to polymorphic differences
between the two genes. Four of these lie within the ADEl coding
region, of which three are silent. The fourth gives rise to a
conservative amino acid change in a region that is not conserved
among S. cerevisiae, B. subtilis and E. coli.
The incomplete ORF corresponding to FUN2 (starting at
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also translated and used to search the NBRF protein database.
The best match found was to folate hydrolase (carboxypeptidase
G2) from Pseudomonas sp. (25). Although the alignment is not
conclusive (23% identity and 69% similarity over a 101 a.a.
block, data not shown), it is not unreasonable that FUN2 may
be involved in folate metabolism. Activated forms of
tetrahydrofolate are substrates, being metabolised to form
tetrahydrofolate, at two points in the purine biosynthesis pathway
in which the ADEJ enzyme functions (26). FUN2, then, may
play a role in the degradation or salvage of the tetrahydrofolate
that is produced, in which case it might be economical and
advantageous for ADE] and FUN2 to be co-ordinately regulated.
Their close proximity and divergently transcribed mRNAs would
allow this.
DISCUSSION
The Tn3 deletion sequencing strategy has some specific
advantages:
1. The method is simple to perform, with no in vitro
manipulations required to make deletions. This may make it
particularly attractive to users who do not wish to spend time
becoming proficient in the often initially troublesome exonuclease
based techniques.
2. Generation of deletions is not labour intensive, even though
the procedure takes four days from having the insert cloned into
the vector to picking sequencing clones. It should be noted that
over these four days, only about four hours of relatively non-
technical work is performed (plus the time spent for one
transformation of E. coli.).
3. The method is inexpensive, requiring only simple media
and no costly enzymes to make ordered deletions.
4. The method generates a mutant bank of transposon
insertions (in addition to a deletion bank) that can be used for
in vivo studies involving gene replacement by homologous
recombination with chromosomal DNA. The transposon m-Tn3
UFO can be selected for in both E. coli and S. cerevisiae.
5. The Tn3 deletion strategy may useful as an initial approach
to a sequencing project. If initial results are unpromising, the
same vectors can be used to make exonuclease HI- or T4
polymerase-mediated deletions using currently available
strategies, so there is no need to re-clone. The converse is not
the case, since most vectors currently in use encode a copy of
the Tn3 38bp repeat which prevents further insertions by Tn3.
Thus, the Tn3 deletion strategy interfaces well with other
strategies.
6. Later in a project, a bias caused by regional specificity of
Tn3 insertion may be detected in the population of sequencing
clones. If this specificity were to take the form of a severe 'cold
spot', it may at some stage become uneconomic to pursue the
Tn3 deletion strategy further. In this case it is possible to apply
other deletion methods to clones already deleted by transposon
mutagenesis. The polylinker in the transposon m-Tn3 FOa can
be used to sequence into the cold spot by exonuclease III- or T4
polymerase-mediated deletions, or the Exometh method.
Alternatively, a cold spot could be subcloned and re-mutagenised.
7. The Tn3 deletion strategy may be uniquely suited to larger
sequencing projects. Exonuclease-based methods can encounter
a sequence dependent, 1-dimensional block to digestion during
the generation of deletions, which may prevent the subsequent
sequencing of a large portion of the insert. The chance of finding
one of these blocks increases with the size of the clone, and the
amount of DNA unsequenceable beyond it increases
exponentially. The strategy described here will probably suffer
more from regional transposition 'cold' or 'hot' spots when
applied to larger clones, but since the method is not 1-dimensional
in nature, the only areas of DNA not sequenced will lie within
those cold spots and not, in addition, beyond them. More
sequence is likely to be obtained from a large fragment, then,
even in the face of these artefacts. We have recently sequenced
a 9.5 kb fragment using the Tn3 deletion strategy (in preparation).
The strategy outlined here also offers opportunities for future
development. The time taken for the Tn3 mutagenesis, for
instance, would be reduced by one day if the fl origin-mediated
deletion event were carried out on the intermediate cointegrate
molecule. Other strategies may also be developed to lessen the
potential effects of site specificity. A single Tn3 38bp terminal
repeat remains in the sequencing clone after the deletion event.
This could be removed by brief exonuclease treatment from a
nearby, unique restriction site (for instance an 8 base pair
recognition site on the transposon, close to the terminal repeat).
The phagemid would then be susceptible to Tn3 transposition
once again. Alternatively, the single-stranded origin deletion
strategy may be adapted for use with gamma delta or other
transposons, which may then be used to create deletions in clones
that have previously been deleted by Tn3. The combined
application of these methods may be a powerful approach to
sequencing even troublesome fragments.
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